Vascular Surgery, Department of Medicine and Surgery, University of Insubria School of Medicine, ASST Settelaghi Universitary Teaching Hospital, Varese, Italy.
Vascular Surgery, Careggi University Teaching Hospital, University of Florence School of Medicine, Florence, Italy.
J Endovasc Ther. 2022 Aug;29(4):565-575. doi: 10.1177/15266028211059908. Epub 2021 Dec 1.
To analyze outcomes following endovascular treatment of total occlusion of the infrarenal aorta and aorto-iliac bifurcation in a multicenter Italian registry.
It is a multicenter, retrospective, observational cohort study. From January 2015 to December 2018, 1306 endovascular interventions for aorto-iliac occlusive disease were recorded in the vascular registry. For this analysis, only patients treated for total occlusion of the infrarenal aorta and aorto-iliac bifurcation were included. Early (<30 days) primary outcomes of interest were technical success and mortality. Late major outcomes were primary and secondary patency and freedom from conversion to open aortic surgery.
A total of 54 (4.1%) patients met the inclusion criteria. Total percutaneous revascularization was possible in 41 (75.9%) patients and hybrid (endo plus open) intervention in 13 (24.1%) patients. The kissing-stent-graft technique was used in 45 (83.3%) cases, covered endovascular reconstruction of the aortic bifurcation (CERAB) in 5 (9.2%), and a unibody endograft deployed in 4 (7.4%). Technical success was 98.1% (n = 53). There were no episodes of intraoperative or perioperative vessel rupture. Conversion to open surgery was not necessary, and there were no in-hospital deaths. The median patient follow-up time was 16 months (interquartrile range [IQR], 6-27). The estimated primary patency rate was 95.8% ± 0.03 (95% confidence interval [CI]: 85.5-98.9) at 1 year, 91.4% ± 0.05 (95% CI: 76.2-97.2) at 2 years, and 85 ± 0.08 (95% CI: 64.5-94.6) at 3 years. Cox regression analysis demonstrated that sex (hazard ratio [HR]: 0.96; 95% CI: 0.15-6.23, = 0.963), extent of the occlusion (HR: 0.28; 95% CI: 0.05-1.46, = 0.130), calcium score (HR: 1.88; 95% CI: 0.31-11.27, = 0.490), or type of endovascular reconstruction (HR: 0.80; 95% CI: 0.13-5.15, = 0.804) did not affect primary patency. Secondary patency was 95.5% ± 0.04 (95% CI: 78.4-99.2) at 3 years. No patients required late conversion to open surgical bypass.
Endovascular reconstruction for total occlusion of the infrarenal aorta and aorto-iliac bifurcation was successful using a combination of percutaneous and hybrid revascularization techniques. Estimated patency rates at 3 years of follow-up are promising and are unaffected by the extent of occlusion or type of revascularization.
在一个多中心的意大利注册中心分析腹主动脉下段和主髂分叉处完全闭塞的血管内治疗的结果。
这是一项多中心、回顾性、观察性队列研究。从 2015 年 1 月至 2018 年 12 月,血管登记处记录了 1306 例主髂动脉闭塞性疾病的血管内介入治疗。在这项分析中,只包括治疗腹主动脉下段和主髂分叉处完全闭塞的患者。早期(<30 天)主要关注的技术结果是技术成功率和死亡率。晚期主要结果是一期和二期通畅率以及免于转为开放主动脉手术。
共有 54 例(4.1%)患者符合纳入标准。41 例(75.9%)患者可进行完全经皮血运重建,13 例(24.1%)患者可进行杂交(腔内加开放)介入。45 例(83.3%)患者使用了吻架技术,5 例(9.2%)使用了分叉部位覆膜血管重建(CERAB),4 例(7.4%)使用了一体式支架。技术成功率为 98.1%(n=53)。无术中或围手术期血管破裂发生。无需转为开放手术,且无院内死亡。中位患者随访时间为 16 个月(四分位距[IQR]:6-27)。1 年时估计一期通畅率为 95.8%±0.03(95%可信区间[CI]:85.5-98.9),2 年时为 91.4%±0.05(95% CI:76.2-97.2),3 年时为 85±0.08(95% CI:64.5-94.6)。Cox 回归分析显示,性别(危险比[HR]:0.96;95%可信区间[CI]:0.15-6.23,=0.963)、闭塞范围(HR:0.28;95% CI:0.05-1.46,=0.130)、钙评分(HR:1.88;95% CI:0.31-11.27,=0.490)或腔内重建类型(HR:0.80;95% CI:0.13-5.15,=0.804)均不影响一期通畅率。二期通畅率为 3 年时的 95.5%±0.04(95% CI:78.4-99.2)。无患者需要晚期转为开放手术旁路。
采用经皮和杂交血运重建技术相结合的方法,对腹主动脉下段和主髂分叉处完全闭塞进行血管内重建是成功的。3 年随访时的估计通畅率很有希望,且不受闭塞范围或血运重建类型的影响。